Want to join the conversation?
$XYL said deal is expected to add to its adjusted earnings in 2017. $XYL will finance all-cash transaction with deployment of about $400MM of its non-U.S. cash, new and existing credit facilities, and combination of short- and long-term debt. There is no change to $XYL's 2016 adjusted earnings outlook. The transaction is expected to close in 4Q16.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)